Press Releases Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Market Closed - Nasdaq Stockholm Other stock markets 11:29:49 2024-04-26 am EDT			5-day change	1st Jan Change
281 ^SEK	+0.07%		+7.66%	+5.24%

Apr. 26	Sobi Wins EU Regulatory Panel's Positive Opinion for Hemophilia A Drug	MT
Apr. 26	Sobi Receives Positive CHMP Opinion Recommending Approval of efanesoctocog alfa for Once-Weekly Treatment of Haemophilia A	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A	Apr. 26	AQ
Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus	Apr. 26	AQ
Swedish Orphan Biovitrum : 25 april - Q1 2024 rapport	Apr. 25	PU
Swedish Orphan Biovitrum : 25 April - Q1 2024 report	Apr. 25	PU
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio	Apr. 25	AQ
Invitation: Sobi's Q1 2024 report	Apr. 15	PU
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)	Apr. 04	AQ
Swedish Orphan Biovitrum : Sobi publishes Annual and sustainability report for 2023	Apr. 02	PU
Sobi publishes Annual and sustainability report for 2023	Apr. 02	AQ
Swedish Orphan Biovitrum : Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP	Mar. 25	PU
Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024	Feb. 08	AQ
Sobi to present new data at EAHAD 2024	Jan. 31	AQ
Sobi's Chairman of the Board resigns due to health reasons	Jan. 05	AQ
Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ)	Nov. 30	AQ
Sobi to present new data at ASH 2023 Annual Meeting	Nov. 20	AQ
Sobi has completed the issuances of series C shares	Nov. 01	AQ
Sobi issues series C shares to fulfil its obligations under outstanding incentive programmes	23-10-31	AQ
Swedish Orphan Biovitrum : 30 October - Q3 2023 report	23-10-30	PU
Sobi publishes Q3 2023 report: Strong revenue and solid performance	23-10-30	AQ
Invitation: Sobi's Q3 2023 report	23-10-18	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Press Releases

Filters